SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is in the spotlight as the company faces backlash over reports that it considered charging traders premium fees for early access to platform posts, fueling community allegations of insider trading and corruption. The stock remains a focal point of intense political division, with participants actively debating the platform's monetization strategies and the broader implications of recent executive communications regarding election integrity.

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is experiencing significant trading volume and upward price momentum, driven by growing investor confidence in its TIL therapy platform and anticipation of upcoming pipeline data. The community is actively discussing the potential for a short squeeze and long-term valuation appreciation, as institutions increase their positions amid speculation of strategic interest in the company's clinical progress.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is trending as investors react to a post-earnings valuation reset, with the stock hitting 52-week lows despite strong fundamentals. While many in the community view the dip as a long-term buying opportunity for a dominant medical robotics leader, others are focused on concerns regarding procedure growth deceleration, competitive pressure, and analyst price target adjustments.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius is facing significant market volatility as investors weigh strong brand growth against short-term headwinds, including concerns over potential UK youth caffeine regulations and broader sector rotation. While the community is divided between frustration over the stock's recent downtrend and bullish sentiment centered on future earnings potential and an alleged short squeeze setup, discussions remain highly focused on whether the dip represents a generational buying opportunity or a deeper structural issue.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is facing significant selling pressure as investors scrutinize the company's progress on its Groves reactor milestones and broader execution risks within the nuclear energy sector. While some retail investors remain bullish on the long-term potential for clean energy infrastructure and AI-driven power demand, the market is currently expressing caution through heavy short interest and concerns over insider selling.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is experiencing intense community debate as traders monitor a critical support level near the $39 range, with many debating whether this serves as a final accumulation bottom or a precursor to further downside. Investors are actively tracking institutional custody news and network transaction metrics while speculating on the impact of upcoming regulatory clarity and potential broader market rotations.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is facing significant downward pressure as retail investors vent frustration over persistent price volatility and recent share dilution, despite ongoing institutional accumulation. While some market participants are positioning for a potential pre-earnings run, the sentiment remains sharply divided as the stock consistently lags behind broader sector rallies.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in Japan, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

GameStop is trending following CEO Ryan Cohen's aggressive pursuit of eBay, an unsolicited $56 billion takeover attempt that the target's board has officially rejected. Investors are actively debating the viability of the deal, the impact of potential share dilution, and whether Cohen's strategy of forcing a hostile acquisition will succeed in unlocking long-term value.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is gaining significant investor attention driven by optimism surrounding their lead oral drug candidate, soquelitinib, and its potential to disrupt the immunology and oncology markets. While the community is actively debating the company's long-term valuation and buyout potential, sentiment is divided between bulls who point to institutional accumulation and positive clinical signals, and bears who express concerns over clinical trial timelines and intense sector competition.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending due to heightened community speculation surrounding the company's upcoming regulatory filings, anticipation of data updates at the ASCO conference, and investor excitement regarding the potential for clinical trial partnerships or an eventual buyout. The community remains focused on the company's progress in expanding trial enrollment and the high-stakes potential of its breast cancer immunotherapy, viewing recent price volatility as a shakeout for retail holders while maintaining long-term confidence in the CEO's execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Replimune Group Inc. Full Year Loss Widens

(RTTNews) - Replimune Group Inc. (REPL) revealed Loss for its full year of -$313.940 million...

REPL Stock Soars on Plans of BLA Resubmission for Melanoma Combo Drug

Replimune stock surges after the company aligned with the FDA on plans to resubmit its BLA for RP1 plus Opdivo in advanced melanoma.

Why Is Replimune Stock Gaining Monday?

Replimune Group (REPL) shares gain on key RP2 & RP1 oncology data presentations at ASCO. Read the clinical trial results.read more...

Why Is REPL Stock Gaining In Pre-Market Today?

Equity

Replimune shares gained ahead of its fourth-quarter earnings report, following positive human-trial data of its immunotherapy RP2.

Replimune, Dell Technologies, NetApp And Other Big Stocks Moving Higher on Friday

US stocks up, Dow Jones up 171 pts. Replimune Group rises after FDA agreement. Other big gainers include Dell, NetApp, and Okta.read more...

REPL Stock Shot Up 80% Today – What’s The Deal With FDA?

Replimune announced it has reached an agreement with the U.S. Food and Drug Administration to resubmit a marketing application for RP1 in combination with Nivolumab to treat advanced melanoma.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Replimune Group, Inc. - REPL INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of...

REPL, QURE Stocks Rise Amid Makary’s Reported Resignation As FDA Chief

The New York Times reported that Makary’s departure was driven in large part by his strong opposition to the administration’s decision to authorize fruit-flavored e-cigarettes.


REPL, QURE, MRNA Soar On Reports Trump Will Fire FDA’s Marty Makary 

The Wall Street Journal reported on the plans on Friday, citing people familiar with the matter, while noting that other top administration officials believe Makary is struggling to manage his agency.


REPL Nosedives As FDA Chief Stands Firm Against Melanoma Treatment: ‘I Don’t Work For Replimune…’

FDA refused to approve Replimune’s melanoma drug RP1 for the second time in April, citing insufficient data to provide “substantial evidence of effectiveness” in the treatment of unresectable advanced cutaneous melanoma.


Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is pacing for a losing week as a semiconductor ($SMH) sell-off has dragged the market lower amid growing doubts about AI spending. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$10.23
Prev Close	$9.52
Open	$9.37
Dividend Yield	0.00%
50-Day Moving Average	$8.36
Beta	0.51
Avg. Volume	4.32M
PE Ratio	-2.92

52-Week High	$13.24
52-Week Low	$1.50
Market Capitalization	$799.34M
EPS (Annual)	-$3.38
Price to Book	5.09
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

REPLReplimune Group Inc

Latest REPL News